Bortezomib and Pemetrexed Disodium in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors
Conditions
- Lung Cancer
- Unspecified Adult Solid Tumor, Protocol Specific
Interventions
- DRUG: bortezomib
- DRUG: pemetrexed disodium
- GENETIC: gene expression analysis
- GENETIC: mutation analysis
- GENETIC: protein expression analysis
- GENETIC: reverse transcriptase-polymerase chain reaction
- OTHER: flow cytometry
- OTHER: immunoenzyme technique
- OTHER: immunohistochemistry staining method
Sponsor
University of California, Davis
Collaborators